Open Actively Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

About

Brief Summary

This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents and young adults can lose weight and develop healthy eating habits.

Primary Purpose
Supportive Care
Study Type
Interventional
Phase
Pilot/Feasibility

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
13 Years
Maximum Age
30 Years

Inclusion Criteria:

  • Patients with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study
  • Patients must classify as obese, represented as body mass index (BMI) >= 85th percentile for age and gender
  • Patients must also be able to read English since the app intervention is only available in English form
  • No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation
  • PARENT:
  • His/her child meets all inclusion criteria
  • = 18 years of age

  • Can speak English

Exclusion Criteria:

  • Patients who are < 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are > 100 days post-transplant at their next consultation that falls within the enrollment window
  • Patients whose BMI does not fall under the obese category will be excluded

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-001992
Category
Oncology
Pediatrics
Contact
Andres Vargas Gonzalez
Location
  • UCLA Westwood
For Providers
NCT No.
NCT04453072
For detailed technical eligibility, visit ClinicalTrials.gov.